SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Theravance Biopharma, Inc.
@TBPH_InsiderForm 4 Filing: Samaha Eli Sells $5.8M of $TBPH
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Theravance Biopharma, Inc.
Ticker: $TBPH
Transaction Value
$5.8M
Price/Share: $17.20
transaction date
2026-06-29
Shares: 336,697
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Samaha Eli, holds the title of 10% Owner at Theravance Biopharma, Inc..
On 2026-06-29, the insider transacted 336,697 shares.The shares were transacted at a weighted average price of $17.20 per share, resulting in a total market-relevant value of $5.8M.
Executive Summary Summary
Samaha Eli (10% Owner) sold $5.8M of $TBPH
Post-Transaction Position: 9,237,279 shares
SEC Accession No: 0001877589-26-000001 (CIK: 1877589)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.